Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Kissei Pharmaceutical had annual revenue of 97.41B JPY with 10.28% growth. Kissei Pharmaceutical had revenue of 24.77B in the quarter ending March 31, 2026, with 9.32% growth.

• Revenue: 97.41B
• Revenue Growth: +10.28%
• P/S Ratio: 1.66
• Revenue / Employee: 54.78M
• Employees: 1,778
• Market Cap: 161.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	97.41B	9.08B	10.28%
Mar 31, 2025	88.33B	12.75B	16.87%
Mar 31, 2024	75.58B	8.09B	11.98%
Mar 31, 2023	67.49B	2.11B	3.23%
Mar 31, 2022	65.38B	-3.66B	-5.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error